Works matching AU Stupp, Roger


Results: 104
    1

    Targeting integrins in malignant glioma.

    Published in:
    2010
    By:
    • Tabatabai, Ghazaleh;
    • Weller, Michael;
    • Nabors, Burt;
    • Picard, Martin;
    • Reardon, David;
    • Mikkelsen, Tom;
    • Ruegg, Curzio;
    • Stupp, Roger
    Publication type:
    journal article
    2
    3

    Anti-O6-Methylguanine-Methyltransferase (MGMT) Immunohistochemistry in Glioblastoma Multiforme: Observer Variability and Lack of Association with Patient Survival Impede Its Use as Clinical Biomarker.

    Published in:
    Brain Pathology, 2008, v. 18, n. 4, p. 520, doi. 10.1111/j.1750-3639.2008.00153.x
    By:
    • Preusser, Matthias;
    • Janzer, Robert Charles;
    • Felsberg, Jörg;
    • Reifenberger, Guido;
    • Hamou, Marie-France;
    • Diserens, Annie-Claire;
    • Stupp, Roger;
    • Gorlia, Thierry;
    • Marosi, Christine;
    • Heinzl, Harald;
    • Hainfellner, Johannes A.;
    • Hegi, Monika
    Publication type:
    Article
    4
    5

    The accuracy of predicting survival in individual patients with cancer.

    Published in:
    Journal of Neurosurgery, 2014, v. 120, n. 1, p. 24, doi. 10.3171/2013.9.JNS13788
    By:
    • KONDZIOLKA, DOUGLAS;
    • PARRY, PHILLIP V.;
    • LUNSFORD, L. DADE;
    • KANO, HIDEYUKI;
    • FLICKINGER, JOHN C.;
    • RAKFAL, SUSAN;
    • ARAI, YOSHIO;
    • RUSH, STEPHEN;
    • LOEFFLER, JAY S.;
    • KNISELY, JONATHAN P. S.;
    • SHEEHAN, JASON;
    • FRIEDMAN, WILLIAM;
    • TARHINI, AHMAD A.;
    • FRANCIS, LANIE;
    • LIEBERMAN, FRANK;
    • AHLUWALIA, MANMEET S.;
    • LINSKEY, MARK E.;
    • MCDERMOTT, MICHAEL;
    • SPERDUTO, PAUL;
    • STUPP, ROGER
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Erratum to: MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status

    Published in:
    2013
    By:
    • Bady, Pierre;
    • Sciuscio, Davide;
    • Diserens, Annie-Claire;
    • Bloch, Jocelyne;
    • Bent, Martin;
    • Marosi, Christine;
    • Dietrich, Pierre-Yves;
    • Weller, Michael;
    • Mariani, Luigi;
    • Heppner, Frank;
    • Macdonald, David;
    • Lacombe, Denis;
    • Stupp, Roger;
    • Delorenzi, Mauro;
    • Hegi, Monika
    Publication type:
    Correction Notice
    12

    MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status.

    Published in:
    Acta Neuropathologica, 2012, v. 124, n. 4, p. 547, doi. 10.1007/s00401-012-1016-2
    By:
    • Bady, Pierre;
    • Sciuscio, Davide;
    • Diserens, Annie-Claire;
    • Bloch, Jocelyne;
    • den Bent, Martin;
    • Marosi, Christine;
    • Dietrich, Pierre-Yves;
    • Weller, Michael;
    • Mariani, Luigi;
    • Heppner, Frank;
    • Mcdonald, David;
    • Lacombe, Denis;
    • Stupp, Roger;
    • Delorenzi, Mauro;
    • Hegi, Monika
    Publication type:
    Article
    13

    Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial.

    Published in:
    Acta Neuropathologica, 2012, v. 123, n. 6, p. 841, doi. 10.1007/s00401-011-0938-4
    By:
    • Hegi, Monika;
    • Janzer, Robert-Charles;
    • Lambiv, Wanyu;
    • Gorlia, Thierry;
    • Kouwenhoven, Mathilde;
    • Hartmann, Christian;
    • Deimling, Andreas;
    • Martinet, Danielle;
    • Besuchet Schmutz, Nathalie;
    • Diserens, Annie-Claire;
    • Hamou, Marie-France;
    • Bady, Pierre;
    • Weller, Michael;
    • den Bent, Martin;
    • Mason, Warren;
    • Mirimanoff, René-Olivier;
    • Stupp, Roger;
    • Mokhtari, Karima;
    • Wesseling, Pieter
    Publication type:
    Article
    14
    15
    16
    17

    DNA methylation-based age acceleration observed in IDH wild-type glioblastoma is associated with better outcome—including in elderly patients.

    Published in:
    Acta Neuropathologica Communications, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40478-022-01344-5
    By:
    • Bady, Pierre;
    • Marosi, Christine;
    • Weller, Michael;
    • Grønberg, Bjørn H.;
    • Schultz, Henrik;
    • Taphoorn, Martin J. B.;
    • Gijtenbeek, Johanna M. M.;
    • van den Bent, Martin J.;
    • von Deimling, Andreas;
    • Stupp, Roger;
    • Malmström, Annika;
    • Hegi, Monika E.
    Publication type:
    Article
    18
    19
    20
    21
    22

    A Neuroradiologist's Guide to Operationalizing the Response Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for Gliomas in Adults.

    Published in:
    American Journal of Neuroradiology, 2024, v. 45, n. 12, p. 1846, doi. 10.3174/ajnr.A8396
    By:
    • Ellingson, Benjamin M.;
    • Sanvito, Francesco;
    • Cloughesy, Timothy F.;
    • Huang, Raymond Y.;
    • Villanueva-Meyer, Javier E.;
    • Pope, Whitney B.;
    • Barboriak, Daniel P.;
    • Shankar, Lalitha K.;
    • Smits, Marion;
    • Kaufmann, Timothy J.;
    • Boxerman, Jerrold L.;
    • Weller, Michael;
    • Galanis, Evanthia;
    • de Groot, John;
    • Gilbert, Mark R.;
    • Lassman, Andrew B.;
    • Shiroishi, Mark S.;
    • Nabavizadeh, Ali;
    • Mehta, Minesh;
    • Stupp, Roger
    Publication type:
    Article
    23
    24

    Development of OXY111A, a novel hypoxiamodifier as a potential antitumor agent in patients with hepato-pancreato-biliary neoplasms - Protocol of a first Ib/IIa clinical trial.

    Published in:
    BMC Cancer, 2016, v. 16, p. 1, doi. 10.1186/s12885-016-2855-3
    By:
    • Limani, Perparim;
    • Linecker, Michael;
    • Kron, Philipp;
    • Samaras, Panagiotis;
    • Pestalozzi, Bernhard;
    • Stupp, Roger;
    • Jetter, Alexander;
    • Dutkowski, Philipp;
    • Müllhaupt, Beat;
    • Schlegel, Andrea;
    • Nicolau, Claude;
    • Lehn, Jean-Marie;
    • Petrowsky, Henrik;
    • Humar, Bostjan;
    • Graf, Rolf;
    • Clavien, Pierre-Alain
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31

    Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.

    Published in:
    2015
    By:
    • Stupp, Roger;
    • Taillibert, Sophie;
    • Kanner, Andrew A.;
    • Kesari, Santosh;
    • Steinberg, David M.;
    • Toms, Steven A.;
    • Taylor, Lynne P.;
    • Lieberman, Frank;
    • Silvani, Antonio;
    • Fink, Karen L.;
    • Barnett, Gene H.;
    • Zhu, Jay-Jiguang;
    • Henson, John W.;
    • Engelhard, Herbert H.;
    • Chen, Thomas C.;
    • Tran, David D.;
    • Sroubek, Jan;
    • Tran, Nam D.;
    • Hottinger, Andreas F.;
    • Landolfi, Joseph
    Publication type:
    journal article
    32
    33
    34
    35

    Corticosteroids compromise survival in glioblastoma.

    Published in:
    2016
    By:
    • Pitter, Kenneth L.;
    • Tamagno, IIaria;
    • Alikhanyan, Kristina;
    • Hosni-Ahmed, Amira;
    • Pattwell, Siobhan S.;
    • Donnola, Shannon;
    • Dai, Charles;
    • Tatsuya Ozawa;
    • Maria Chang;
    • Chan, Timothy A.;
    • Beal, Kathryn;
    • Bishop, Andrew J.;
    • Barker, Christopher A.;
    • Jones, Terreia S.;
    • Hentschel, Bettina;
    • Gorlia, Thierry;
    • Schlegel, Uwe;
    • Stupp, Roger;
    • Weller, Michael;
    • Holland, Eric C.
    Publication type:
    journal article
    36
    37
    38
    39
    40
    41
    42

    Targeting brain-tumor stem cells.

    Published in:
    Nature Biotechnology, 2007, v. 25, n. 2, p. 193, doi. 10.1038/nbt0207-193
    By:
    • Stupp, Roger;
    • Hegi, Monika E.
    Publication type:
    Article
    43

    Current concepts and management of glioblastoma.

    Published in:
    Annals of Neurology, 2011, v. 70, n. 1, p. 9, doi. 10.1002/ana.22425
    By:
    • Preusser, Matthias;
    • de Ribaupierre, Sandrine;
    • Wöhrer, Adelheid;
    • Erridge, Sara C.;
    • Hegi, Monika;
    • Weller, Michael;
    • Stupp, Roger
    Publication type:
    Article
    44
    45

    T-cell activation by treatment of cancer patients with EMD 521873 (Selectikine), an IL-2/anti-DNA fusion protein.

    Published in:
    Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-5
    By:
    • Laurent, Julien;
    • Touvrey, Cedric;
    • Gillessen, Silke;
    • Joffraud, Magali;
    • Vicari, Manuela;
    • Bertrand, Caroline;
    • Ongarello, Stefano;
    • Liedert, Bernd;
    • Gallerani, Elisa;
    • Beck, Joachim;
    • Omlin, Aurelius;
    • Sessa, Cristiana;
    • Quaratino, Sonia;
    • Stupp, Roger;
    • Gnad-Vogt, Ulrike S.;
    • Speiser, Daniel E.
    Publication type:
    Article
    46

    Long-term outcomes of central neurocytoma – an institutional experience.

    Published in:
    Journal of Neuro-Oncology, 2024, v. 169, n. 1, p. 195, doi. 10.1007/s11060-024-04713-3
    By:
    • Yang, Yufan;
    • Wadhwani, Nitin;
    • Shimomura, Aoi;
    • Zheng, Shuhua;
    • Chandler, James;
    • Lesniak, Maciej S.;
    • Tate, Matthew C.;
    • Sonabend, Adam M.;
    • Kalapurakal, John;
    • Horbinski, Craig;
    • Lukas, Rimas;
    • Stupp, Roger;
    • Kumthekar, Priya;
    • Sachdev, Sean
    Publication type:
    Article
    47

    Leptomeningeal metastases: the future is now.

    Published in:
    Journal of Neuro-Oncology, 2022, v. 156, n. 3, p. 443, doi. 10.1007/s11060-021-03924-2
    By:
    • Lukas, Rimas V.;
    • Thakkar, Jigisha P.;
    • Cristofanilli, Massimo;
    • Chandra, Sunandana;
    • Sosman, Jeffrey A.;
    • Patel, Jyoti D.;
    • Kumthekar, Priya;
    • Stupp, Roger;
    • Lesniak, Maciej S.
    Publication type:
    Article
    48
    49
    50

    Do statins, ACE inhibitors or sartans improve outcome in primary glioblastoma?

    Published in:
    Journal of Neuro-Oncology, 2018, v. 138, n. 1, p. 163, doi. 10.1007/s11060-018-2786-8
    By:
    • Happold, Caroline;
    • Gorlia, Thierry;
    • Nabors, L. Burt;
    • Erridge, Sara C.;
    • Reardon, David A.;
    • Hicking, Christine;
    • Picard, Martin;
    • Stupp, Roger;
    • Weller, Michael;
    • For the EORTC Brain Tumor Group and on behalf of the CENTRIC and CORE Clinical Trial Groups
    Publication type:
    Article